Skip to Main Content

Paper Details

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.
Nat Genet
381
2016
ALS, C21orf2, MOBP, SCFD1, amyotrophic lateral sclerosis, associated, chromosome 21, patients, risk loci, risk locus, risk variants, whole-genome
Author NameAffiliation
Sara L PulitCenter for Molecular Medicine, University Medical Center Utrecht
Simone de JongInstitute of Psychiatry, King's College London
Simone de JongNIHR Biomedical Research Centre for Mental Health, Maudsley Hospital and Institute of Psychiatry, King's College London
Jian YangQueensland Brain Institute, University of Queensland
Kuang LinMaurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King's College London
Pamela J ShawSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
John Q TrojanowskiCenter for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania
Thomas MeitingerInstitute of Human Genetics
Thomas MeitingerInstitute of Human Genetics
Peter LichtnerInstitute of Human Genetics
Alexis BriceINSERM U7
Alexis BriceCNRS UMR 5
Alexis BriceSorbonne Universites
Alexis BriceInstitut du Cerveau et de la Moelle Epiniere
Alexis Brice
Alexandra DurrInstitut du Cerveau et de la Moelle Epiniere
Nicholas W WoodInstitute of Neurology, University College London
Nicholas W WoodInstitute of Neurology, University College London
Wolfgang LiebPopGen Biobank and Institute of Epidemiology, Christian Albrechts University Kiel
Andre FrankeInstitute of Clinical Molecular Biology, Kiel University
Andre FrankeInstitute of Clinical Molecular Biology, Kiel University
Marcella RietschelCentral Institute of Mental Health, University of Heidelberg
Sven CichonInstitute of Human Genetics, University of Bonn
Sven Cichon
Sven CichonUniversity Hospital Basel, University of Basel
Sven CichonUniversity of Basel
Sven CichonInstitute of Neuroscience and Medicine INM-1, Research Center Juelich
Markus M N??thenInstitute of Human Genetics, University of Bonn
Markus M N??then
Markus M N??thenInstitute of Human Genetics, University of Bonn
Markus M N??then
Philippe AmouyelUniversity of Lille, INSERM, CHU de Lille, Institut Pasteur de Lille
Andr?? G UitterlindenErasmus Medical Center Rotterdam
Andr?? G UitterlindenErasmus Medical Center Rotterdam
Andr?? G UitterlindenErasmus Medical Center Rotterdam
Andr?? G UitterlindenErasmus Medical Center Rotterdam
Fernando RivadeneiraErasmus Medical Center Rotterdam
Fernando RivadeneiraErasmus Medical Center Rotterdam
Fernando RivadeneiraErasmus Medical Center Rotterdam
Fernando RivadeneiraErasmus Medical Center Rotterdam
Karol EstradaErasmus Medical Center Rotterdam
Karol EstradaErasmus Medical Center Rotterdam
Albert HofmanErasmus Medical Center Rotterdam
Albert HofmanHarvard T.H. Chan School of Public Health
Albert HofmanErasmus Medical Center Rotterdam
Albert HofmanHarvard T.H. Chan School of Public Health
Charles CurtisInstitute of Psychiatry, King's College London
Charles CurtisNIHR Biomedical Research Centre for Mental Health, Maudsley Hospital and Institute of Psychiatry, King's College London
An GorisLeuven Research Institute for Neuroscience and Disease (LIND), KU Leuven-University of Leuven
Sandra D'AlfonsoInterdisciplinary Research Center of Autoimmune Diseases, Universita del Piemonte Orientale
  • 1 - 50

Datasets